Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

FTSE AIM All-Share: Diagnostics Momentum Puts Cambridge Cognition Holdings plc (LSE:COG)

October neuroscience and Alzheimer’s-focused developments reinforce the digital cognitive-assessment growth story after strong H1Revenuegrowth.

Ankur Sharma | 09 November 2026

CRISM Therapeutics (LSE:CRTX) in Focus Today: CRISM Therapeutics remains in focus around its oncology-focused therapeutic platform and the development milestones that could validate its technology.

On 9 November 2026, CRISM Therapeutics (LSE:CRTX) is in focus as investors assess the latest company-specific catalyst and what it could mean for the next stage of the business. The immediate reason for attention is crism therapeutics remains in focus around its oncology-focused therapeutic …

Ankur Sharma | 09 November 2026

FTSE AIM All-Share: Diagnostics Momentum Puts EDX Medical Group plc (LSE:EDX)

Recent board and investor updates, including a leading-industry-figure chair appointment, have refocused attention on commercial execution.

Ankur Sharma | 09 November 2026

Futura Medical (LSE:FUM) in Focus Today: Board change and formal sale-process progress have put Futura Medical back on the corporate-action radar, with an information memorandum circulating to interested parties.

On 9 November 2026, Futura Medical (LSE:FUM) is in focus as investors assess the latest company-specific catalyst and what it could mean for the next stage of the business. The immediate reason for attention is board change and formal sale-process progress have put futura …

Ankur Sharma | 09 November 2026

FTSE AIM All-Share: Diagnostics Momentum Puts Genedrive plc (LSE:GDR)

The molecular diagnosticsBusinessremains in focus around product adoption, regulatory progress and commercial partnerships.

Ankur Sharma | 09 November 2026

GENinCode (LSE:GENI) in Focus Today: Investor attention remains on GENinCode's genomic testing platform and the commercial adoption of its cardiovascular and cancer-risk testing products.

On 9 November 2026, GENinCode (LSE:GENI) is in focus as investors assess the latest company-specific catalyst and what it could mean for the next stage of the business. The immediate reason for attention is investor attention remains on genincode's genomic testing platform and the …

Ankur Sharma | 09 November 2026

Kooth (LSE:KOO) in Focus Today: Kooth remains in focus as investors assess the pace of digital mental-health adoption, public-sector contracts and the company's route toward sustainable growth.

On 9 November 2026, Kooth (LSE:KOO) is in focus as investors assess the latest company-specific catalyst and what it could mean for the next stage of the business. The immediate reason for attention is kooth remains in focus as investors assess the pace of …

Ankur Sharma | 09 November 2026

FTSE AIM All-Share: Diagnostics Momentum Puts Oxford BioDynamics plc (LSE:OBD)

5 November first pharmaceutical agreement for EpiSwitch Orion, following a delayed-settlement update earlier in November.

Ankur Sharma | 09 November 2026

Proteome Sciences (LSE:PRM) in Focus Today: Recent clinical chemoproteomics contract wins and the September interim results continue to support investor focus on the company's specialist proteomics platform.

On 9 November 2026, Proteome Sciences (LSE:PRM) is in focus as investors assess the latest company-specific catalyst and what it could mean for the next stage of the business. The immediate reason for attention is recent clinical chemoproteomics contract wins and the september interim …

Ankur Sharma | 09 November 2026

Provexis (LSE:PXS) in Focus Today: Investor focus remains on Provexis's Fruitflow platform, licensing relationships and the ability to convert its functional-food science into recurring commercial income.

On 9 November 2026, Provexis (LSE:PXS) is in focus as investors assess the latest company-specific catalyst and what it could mean for the next stage of the business. The immediate reason for attention is investor focus remains on provexis's fruitflow platform, licensing relationships and …

Ankur Sharma | 09 November 2026
Support

Hi! How can we help you today?

Loading…